The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Each year for the past three years, there have been about 50 new molecular medicines approved by the United States Food & Drug Administration (FDA), of which approximately 25% were new biopharmaceuticals. Over 200 recombinant proteins, monoclonal antibodies, antibody drug conjugates, fusion prot...

Descripción completa

Detalles Bibliográficos

Autor principal:	Geigert, John (Autor)
Autor Corporativo:	SpringerLink (Online service)
Formato:	Electrónico eBook
Lenguaje:	inglés
Publicado:	Cham : Springer Nature Switzerland : Imprint: Springer, 2023.
Edición:	4th ed. 2023.
Materias:	Biologicals. Biopharmaceutics. Pharmaceutical chemistry. Pharmacy. Biologics. Pharmaceutics.
Acceso en línea:	https://doi.org/10.1007/978-3-031-31909-9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!